Results 271 to 280 of about 334,749 (357)

Molecular mimicry and cancer vaccine development. [PDF]

Mol Cancer, 2023
Tagliamonte M, Cavalluzzo B, Mauriello A, Ragone C, Buonaguro FM, Tornesello ML, Buonaguro L.   +6 more
europepmc   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

BMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah, Xingxing Li, Hao Yuan, Huiling Shen, Shaohao Quan, Guifang Pan, Muhammad Ishfaq, Abid Ullah Shah, Hanhan Xie, Jundong Shao   +9 more
wiley   +1 more source

Cancer vaccines: progress reveals new complexities

, 2002
Zhiya Yu, Nicholas P. Restifo
openalex   +2 more sources

Unlocking cancer vaccine potential: What are the key factors? [PDF]

Hum Vaccin Immunother
Grant M, Ni Lee L, Chinnakannan S, Tong O, Kwok J, Cianci N, Tillman L, Saha A, Pereira Almeida V, Leung C.   +9 more
europepmc   +1 more source

Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy [PDF]

, 2003
Gabriela Gonzalez, Tania Crombet, F. Torres, Mauricio Catalá, Lloyd F. Alfonso, Marta Osorio, Elia Neninger, Beatriz García Verdecia, A. Obrador Mulet, Rolando Pérez, Ricardo da Cruz Lage   +10 more
openalex   +1 more source

Designing next‐generation immune cell therapies with nanomaterials

BMEMat, EarlyView.
Nanomaterials are transforming immune cellular therapies (ICT) by addressing challenges like tumor accessibility and lengthy manufacturing. This perspective highlights innovations such as magnetic nanoparticles for target identification, lipid nanoparticles for T cell stimulation, and nanoparticle‐mediated gene cytokine delivery. These advances promise
Kangfu Chen, Wenhan Wang, Zongjie Wang
wiley   +1 more source

Engineered mitochondria exert potent antitumor immunity as a cancer vaccine platform. [PDF]

Cell Mol Immunol
Luo J, Mo F, Zhang Z, Hong W, Lan T, Cheng Y, Fang C, Bi Z, Qin F, Yang J, Zhang Z, Li X, Que H, Wang J, Chen S, Wu Y, Yang L, Li J, Wang W, Chen C, Wei X.   +20 more
europepmc   +1 more source

Mimotopes of Tumor-Associated T-Cell Epitopes for Cancer Vaccines Determined with Combinatorial Peptide Libraries [PDF]

, 2003
Tumenjargal Sherev, Karl‐Heinz Wiesmüller, Peter Walden   +2 more
openalex   +1 more source

Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma. [PDF]

Blood Adv
Ramirez CA, Becker-Hapak M, Singhal K, Russler-Germain DA, Frenkel F, Barnell EK, McClain ED, Desai S, Schappe T, Onyeador OC, Kudryashova O, Belousov V, Bagaev A, Ocheredko E, Kiwala S, Hundal J, Skidmore ZL, Watkins MP, Mooney TB, Walker JR, Krysiak K, Gomez F, Fronick CC, Fulton RS, Schreiber RD, Mehta-Shah N, Cashen AF, Kahl BS, Ataullakhanov R, Bartlett NL, Griffith M, Griffith OL, Fehniger TA.   +32 more
europepmc   +1 more source

Vaccines: The Next Step for Cervical Cancer Prevention?

, 2001
Katrin Arnold
openalex   +1 more source